Decentralized clinical trials permit the industry to shape protocols around patients in hopes of decreasing burden, but will decentralization also finally transform clinical trial execution, and drug development as a whole?
In this article published in PharmaVoice, Maria Fotiu, Executive VP, Decentralized Solutions, provides her point of view on the role decentralization can play in the evolution of drug development.
Download the Full Article Below
